Screener
Zimmer Biomet Holdings ZBH Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Hips | $562.7M+5.0% | $524.1M+5.7% | $555.4M+6.8% | $506.2M+5.1% | $536.1M+5.8% | |
| Knees | $828.9M+0.4% | $828.6M+4.5% | $911.1M+8.6% | $792.4M+6.3% | $826M+3.1% | |
| SET | $586M+6.4% | $562.2M+19.5% | $587.6M+20.1% | $541.5M+19.2% | $550.6M+17.3% | |
| Technology And Data Bone Cement And Surgical | $199.4M+21.1% | $171.8M+14.6% | $189.7M+8.6% | $161.3M+12.5% | $164.6M-0.2% | |
| Revenue by Geography | ||||||
| Americas | $1.36B+5.6% | $1.32B+9.7% | $1.41B+11.0% | $1.25B+10.4% | $1.29B+7.3% | |
| Asia Pacific | $339.5M+2.2% | $272.3M+4.5% | $329.4M+5.4% | $330.9M+6.1% | $332.2M+7.1% | |
| EMEA | $478.5M+4.5% | $489.9M+10.9% | $501.3M+14.5% | $417M+10.8% | $458.1M+5.9% | |
| US | $1.24B+5.6% | $1.21B+8.6% | $1.31B+11.1% | $1.16B+10.6% | $1.17B+6.1% |
FAQ
- How does Zimmer Biomet Holdings break its business down?
- Zimmer Biomet Holdings (ZBH) reports revenue by product across 4 parts — Hips, Knees, SET and Technology And Data Bone Cement And Surgical. Each is extracted from the segment footnotes and tracked over time.
- Where does Zimmer Biomet Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Zimmer Biomet Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
